Long-acting beta2- adrenoreceptor agonists : salmeterol and formoterol
Lorna Marie West
Abstract
Open-access reader
Lorna Marie West
Abstract
Open-access reader
The long-acting beta2 -adrenoreceptor agonists salmeterol and formoterol, given by inhalation, have a bronchodilating effect lasting for at least 12 hours after a single administration. They complement but not substitute inhaled glucocorticoids in the management of asthma and are also used in the management of chronic obstructive pulmonary disease (COPD).
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The long-acting beta2 -adrenoreceptor agonists salmeterol and formoterol, given by inhalation, have a bronchodilating effect lasting for at least 12 hours after a single administration. They complement but not substitute inhaled glucocorticoids in the management of asthma and are also used in the management of chronic obstructive pulmonary disease (COPD).
Key concepts: Salmeterol, Formoterol, B2 receptor, Formoterol Fumarate, Medicine, Pharmacology, COPD, Asthma